Lung Cancer Update cover image

Striving for Consensus on the Management of ALK-Positive Lung Cancer

Lung Cancer Update

00:00

Is There a Difference Between on Target Resistance and Off Target Resistance?

Ross: Would somebody who progressed after a year and a half make you nervous that maybe something else is going on? Justin: We need to draw a distinction between clear evidence of benefit and then the development of resistance. Ross: I'm curious how you approach patients who are non-smokers and yet on next generation sequencing don't have anything. What about RNA sequencing, other assays and when you do that what do you find?

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app